Close
4

Bora CDMO Bora CDMO

X

Company profile for Shanghai Soho-Yiming Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Soho-Yiming Pharmaceuticals Co.,Ltd(a wholly owned subsidiary by Ankebio) was founded in 2001. It is a high-tech enterprise focused on research, development, production and sales of different kinds GMP peptide API. Our company owns the first-class facilities of experiment and production, such as automatic peptide synthesis system, separation and purification system, freeze drying system and other instruments. By introducing, ...
Soho-Yiming Pharmaceuticals Co.,Ltd(a wholly owned subsidiary by Ankebio) was founded in 2001. It is a high-tech enterprise focused on research, development, production and sales of different kinds GMP peptide API. Our company owns the first-class facilities of experiment and production, such as automatic peptide synthesis system, separation and purification system, freeze drying system and other instruments. By introducing, digesting, absorbing the most advanced peptide synthesis technology in the world, we have established a leading high-tech platform for active small molecule peptide drugs in China.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Shanghai Soho-Yiming Pharmaceuticals
China Flag
Country
Country
China
Address
Address
1277 Huaqing Road, Qingpu District, Shanghai
Telephone
Telephone
+86-21-52690300
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY